title: Major bleeding in acute coronary syndromes.
abstract: Treatment of acute coronary syndrome has been based on the prevention of ischemic complications by means of antithrombotic therapy and invasive strategies. The desired reduction reached in the recurrence of ischemic events reveals its price, an increase in the occurrence of major bleeding. Initially tolerated as a benign complication, it is now shown to be an important predictor of mortality. Greater attention dedicated to the prognostic impact of bleeding is recent, motivated by the development of new antithrombotic agents. Detailed analysis of the risk factors for myocardial infarction or bleeding is an important issue and allows institution of individualized approach.
authors: Invasive Cardiology, Santa Casa de Marília Av. Vicente Ferreira, 828-Cascata, Marília, São Paulo, Brazil 17515-900. pedroberaldo@gmail.com
authors: Pedro Beraldo
authors: PB
authors: de Andrade
authors: Marden André
authors: MA
authors: Tebet
authors: Felipe Souza
authors: FS
authors: Maia da Silva
authors: Mônica Vieira
authors: MV
authors: Athanazio de Andrade
authors: André
authors: A
authors: Labrunie
authors: Luiz Alberto
authors: LA
authors: Piva E Mattos
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D003324:Coronary Artery Disease / Q000628:therapy*; D004305:Dose-Response Relationship, Drug; D005263:Femoral Artery; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006470:Hemorrhage / Q000145:classification / Q000453:epidemiology*; D006801:Humans; D007511:Ischemia / Q000517:prevention & control*; D017534:Radial Artery; D012307:Risk Factors
chemical_list: D005343:Fibrinolytic Agents